Trial · NCT04020016
Adverse events75
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 75
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Vomiting | Gastrointestinal disorders | Cohort 1: NAL ER 27 mg | 2 | 16 | |
| other | Vomiting | Gastrointestinal disorders | Cohort 2: NAL ER 54 mg | 1 | 15 | |
| other | Vomiting | Gastrointestinal disorders | Cohort 3: NAL ER 108 mg | 0 | 15 | |
| other | Vomiting | Gastrointestinal disorders | Cohort 4: NAL ER 162 mg | 1 | 13 | |
| other | Vomiting | Gastrointestinal disorders | Cohort 5: NAL ER 162 mg | 3 | 8 | |
| other | Nausea | Gastrointestinal disorders | Cohort 1: NAL ER 27 mg | 1 | 16 | |
| other | Nausea | Gastrointestinal disorders | Cohort 2: NAL ER 54 mg | 0 | 15 | |
| other | Nausea | Gastrointestinal disorders | Cohort 3: NAL ER 108 mg | 1 | 15 | |
| other | Nausea | Gastrointestinal disorders | Cohort 4: NAL ER 162 mg | 0 | 13 | |
| other | Nausea | Gastrointestinal disorders | Cohort 5: NAL ER 162 mg | 1 | 8 | |
| other | Dry Mouth | Gastrointestinal disorders | Cohort 1: NAL ER 27 mg | 0 | 16 | |
| other | Dry Mouth | Gastrointestinal disorders | Cohort 2: NAL ER 54 mg | 0 | 15 | |
| other | Dry Mouth | Gastrointestinal disorders | Cohort 3: NAL ER 108 mg | 0 | 15 | |
| other | Dry Mouth | Gastrointestinal disorders | Cohort 4: NAL ER 162 mg | 2 | 13 | |
| other | Dry Mouth | Gastrointestinal disorders | Cohort 5: NAL ER 162 mg | 0 | 8 | |
| other | Euphoric Mood | Psychiatric disorders | Cohort 1: NAL ER 27 mg | 0 | 16 | |
| other | Euphoric Mood | Psychiatric disorders | Cohort 2: NAL ER 54 mg | 0 | 15 | |
| other | Euphoric Mood | Psychiatric disorders | Cohort 3: NAL ER 108 mg | 2 | 15 | |
| other | Euphoric Mood | Psychiatric disorders | Cohort 4: NAL ER 162 mg | 7 | 13 | |
| other | Euphoric Mood | Psychiatric disorders | Cohort 5: NAL ER 162 mg | 0 | 8 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04020016/events